Modern approach to the diagnosis and treatment of anxiety disorders


DOI: https://dx.doi.org/10.18565/therapy.2018.7-8.63-69

E.A. Korabelnikova

The Department of nervous diseases of «I.M. Sechenov First Moscow State Medical University» FSAEI of HE of the Ministry of Health of Russia (Sechenov University)
Article contains the characteristics of anxiety disorders from the standpoint of etiopathogenesis, classification, clinical features, pathomorphosis. The etiopathogenetic correlation between somatic diseases and anxiety disorders is shown. The necessity of complex approach to the treatment of anxiety disorders, which, in parallel with appropriate pharmacotherapy, includes a wide range of psychotherapeutic, physiotherapeutic and social rehabilitation measures, is grounded.
Keywords: anxiety, anxiety disorders, pharmacotherapy, psychotherapy
Read entire article

Literature

  • Sotres-Bayon F., Diaz-Mtaix L., Bush D.E.A., LeDoux J.E. Dissociable roles for the ventromedial prefrontal cortex and amygdala in fear extinction:NR2B contribution. Cereb. Cortex 2009; 19: 474–82. pmid 18562331.
  • Корабельникова Е.А., Будик А.М. Клинико-патогенетические и терапевтические аспекты тревожных расстройств. Лечащий врач. 2009; 9; 36–42.
  • Yerkes R., Dodson J. The relation of strength of stimulus to rapidity of habit–formation. J. Comp. Neurol. Psychol. 1908; 18: 459–82.
  • Березин Ф.Б. Психическая и психофизиологическая адаптация человека. Л., 1988. 270 с.
  • Бобров А.Е. Тревожные расстройства: их систематика, диагностика и фармакотерапия. РМЖ. 2006; 4: 328–332.
  • Klein E., Koren D., Aron I. Sleep cmplaints are not corroborated by objective sleep measures in post-traumatic stress disorder: a 1-etar prospective study in survivors of motor vehicles crashes. J. Sleep Res. 2003; 12: 35–41.
  • The ESEMed/MHEDEA 2000 Investigators. Disability and quality of life impact of mental disorders in Europe: results from the European study of the epidemiology of mental disorders (ESEMeD) project. Acta Psychiatr. Scand. 2004; 109(420): 38–46.
  • Будик А.М., Корабельникова Е.А. Тревога как клинико-психофизиологический феномен. Обозрение психиатрии и медицинской психологии. 2009; 4: 73–75.
  • National Institutes of Health. Phobias: MedlinePlus. National Library of Medicine -National Institutes of Health. 2011. Retrieved May 12. Available from: http://www.nlm.nih.gov/medlineplus/phobias.html.
  • Вербицкий Е.В. Тревожность и сон. Журнал высшей нервной деятельности. 2013; 63(1): 6–12.
  • Гордеев С.А. Изменения спонтанной и вызванной электрической активности мозга при тревожно-фобических расстройствах. Неврологический вестник. 2008; XL(1): 81–87.
  • Insel T.R., Ninan P.T., Aloy J. el al. A benzodiazepine receptor mediated model of anxiety: Studies in non-hyman primates and clinical implications. Arch. Gen. Psychiatry. 1984; 41: 741–50.
  • Левин О.С. Тревожные расстройства в общеклинической практике. Медицинский совет. 2017; 10: 36–40.
  • Психические расстройства и расстройства поведения (F00–F99). Класс V МКБ-10, адаптированный для использования в Российской Федерации. Под ред. В.Б. Голланда, Т.Б. Дмитриевой, Б.А. Казаковцева. М., 1998.


    • About the Autors

    Elena A. Korabelnikova, MD, professor of the Department of nervous diseases of the Institute of Professional Education «I.M. Sechenov First Moscow State Medical University» FSAEI of HE of the Ministry of Healthcare of Russia (Sechenov University). Address: 111123, Moscow, 86 Shosse Enthuziastov St. Tel. +7(910)414-09-34. E-mail: e_korabel@mail.ru

    Back to Content

    Бионика Медиа